Annual Twin Cities Hematological Malignancy Symposium
About Us
The Twin Cities Hematologic Malignancies Symposium is an annual event organized by the Malignant Hematology Section in partnership with the Bone Marrow Transplant and Cell Therapy Section and is endorsed by Masonic Cancer Center.
The symposium brings together experts in hematologic malignancies to share the latest advances in diagnosis, treatment, and patient care.
From Dr. Veronika Bachanova
As Section Head of Hematologic Malignancies, I’m proud to co-host this event and invite you to join us for our Annual Hematologic Malignancies Symposium. This event continues to grow each year thanks to the strength of our community and shared commitment to advancing care. We all look forward to sharing a rewarding experience filled with learning, collaboration and meaningful connections.
Previous Events
June 25, 2026
AML
“Resolving Barriers to allogeneic Transplant for Patients with AML and MDS”
Mark Juckett, MD
“Less-intensive induction for AML: is the Paradigm changing?”
Jeremy Allred, MD
AML Panel w/Guest Speakers
Mark Juckett, MD; Jeremy Allred, MD; Fiona He, MD; Gordon Ruan, MD; George Scaria, MD
Myeloma
“The Evolving Landscape of Frontline Therapy in Multiple Myeloma”
Binoy Yohannan, MD
“Updates in Relapsed/Refractory Multiple Myeloma”
Daniel O’Leary, MD
Myeloma Panel w/Guest Speakers
Binoy Yohannan, MD; Daniel O’Leary, MD; Joseph Levine, MD
Lymphoma
“Advances in CAR-T Cell Therapy: Expanding Cure and Enhancing Safety”
Veronika Bachanova, MD, PhD
“Bispecifics in B-cell Lymphoma: A New Era”
Marie Hu, MD
Lymphoma Panel w/Guest Speakers
Veronika Bachanova,MD, PhD; Marie Hu, MD; Brittany Letcher,MSN, RN, OCN; Aquino Williams, MD
Event Details
2027
TBA
Contact Us
Sabrina Porter
[email protected]